Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: RXRX

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General
  • Hedge Funds
  • Trading Ideas

Cathie Wood’s ARK Invest Posts Fund Purchases For Thursday, July 8, 2021: SGFY, MASS, QSI, RPTX, RXRX, COIN, FATE, PATH, KTOS, FTCH, VUZI, U

By Michael Horton
Today, 7:29 AM
Signify Health (SGFY) - 90,214 Shares 908 Devices (MASS) - 18,400 Quantum-Si (QSI) - 231,750 Repare Therapeutics (RPTX) - 11,285 Recursion Pharmaceuticals (RXRX) - 45,992 Coinbase Global (COIN) - 255,478 Fate

COIN

Read More
5 minute read
  • Biotech
  • FDA
  • General
  • IPOs
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Top Stories

The Daily Biotech Pulse: Lilly, Morphic’s Positive Data At ECCO, Humanigen’s COVID Treatment Gets Expedited Review In UK, TransCode IPO

By Shanthi Rexaline
Today, 7:29 AM
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8)

ABCL

Read More
1 minute read
  • General
  • Hedge Funds
  • Trading Ideas

Cathie Wood’s ARK Invest Posts Fund Purchases For Wednesday, July 7, 2021: PATH, SGFY, RXRX, RPTX, QSI, MASS, FATE, COIN, TSLA, VUZI, FTCH, AVAV

By Michael Horton
Today, 7:29 AM
UiPath (PATH) - 440,157 Shares Signify Health (SGFY) - 53,916 Recursion Pharmaceuticals (RXRX) - 204,752 Repare Therapeutics (RPTX) - 18,190 Quantum-Si (QSI) - 359,389 908 Devices (MASS) - 47,945 Fate

AVAV

Read More
5 minute read
  • Biotech
  • FDA
  • Guidance
  • News
  • Offerings
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Top Stories

The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend

By Shanthi Rexaline
Today, 7:29 AM
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6)

ABCL

Read More
5 minute read
  • Biotech
  • IPOs
  • News
  • Offerings
  • Penny Stocks
  • Small Cap

The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs

By Shanthi Rexaline
Today, 7:29 AM
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29)

ACHL

Read More
2 minute read
  • Contracts
  • News

Recursion Announces Multi-Year Collaboration With Mila For Tech-Enabled Drug Discovery

By Benzinga Newsdesk
Today, 7:29 AM
Recursion (NASDAQ:RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering, today announced a

RXRX

Read More
5 minute read
  • Biotech
  • FDA
  • News
  • Offerings
  • Penny Stocks
  • Small Cap

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy’s Launches Generic Vascepa, Halozyme Strikes Licensing Deal

By Shanthi Rexaline
Today, 7:29 AM
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21)

ABCL

Read More
2 minute read
Uncategorized

Cathie Wood Cuts Apple Stake Almost Entirely — And Buys More Coinbase

By Rachit Vats
Today, 7:29 AM
Cathie Wood-led Ark Investment Management on Monday shed nearly all of its stake in Apple Inc (NASDAQ: AAPL) and continued to snap up shares of Coinbase Global Inc (NASDAQ: COIN).

AAPL

Read More
2 minute read
Uncategorized

Cathie Wood Buys $26M Disney Shares And Sells $13M In Netflix: What You Need To Know

By Rachit Vats
Today, 7:29 AM
Cathie Wood-led Ark Investment Management on Friday bought 150,556 shares, worth about $26.15 million, in Walt Disney Co (NYSE: DIS), marking its debut in the media and entertainment company as analysts pointed to benefits from the reopening of theme parks in 2021.

ACCD

Read More
5 minute read
Uncategorized

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts

By Shanthi Rexaline
Today, 7:29 AM
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13)

ACHL

Posts navigation

Previous 1 … 4 5 6 7 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service